Japan's Daiichi Sankyo says mRNA COVID vaccine successful in booster trial | Reuters

Retrieved on: 2022-11-15 05:01:51

Tags for this article:

Click the tags to see associated articles and topics

Japan's Daiichi Sankyo says mRNA COVID vaccine successful in booster trial | Reuters. View article details on hiswai:

Excerpt

Japan's Daiichi Sankyo Co said on Tuesday its mRNA-based COVID-19 vaccine had reached its primary endpoint in a trial of the shot as a booster.

Article found on: www.reuters.com